Cargando…
Serum Albumin Still of Interest to Predict Outcomes in Membranous Nephropathy in the Era of Phospholipase A2 Receptor
Autores principales: | Delafosse, Marion, Ponlot, Eléonore, Hanset, Nicolas, Estève, Emmanuel, Boffa, Jean-Jaques, Dahan, Karine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486175/ https://www.ncbi.nlm.nih.gov/pubmed/32954089 http://dx.doi.org/10.1016/j.ekir.2020.06.040 |
Ejemplares similares
-
Rituximab in Patients With Phospholipase A2 Receptor–Associated Membranous Nephropathy and Severe CKD
por: Hanset, Nicolas, et al.
Publicado: (2019) -
Apixaban Prophylactic Anticoagulation in Patients with Nephrotic Syndrome
por: Van Meerhaeghe, Tess, et al.
Publicado: (2022) -
Steroids: A Therapeutic Option for COVID-19 Pneumonia Patients With ESRD?
por: Delafosse, Marion, et al.
Publicado: (2020) -
Phospholipase‐A2 receptor antibody, 24 hours proteinuria, and serum albumin as indicators of cyclophosphamide efficacy in idiopathic membranous nephropathy
por: Xiao, Chunying, et al.
Publicado: (2020) -
Why 24-h Urine Albumin Excretion Rate Method Still is Used for Screening of Diabetic Nephropathy in Isfahan Laboratories?
por: Teimoury, Azam, et al.
Publicado: (2014)